BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16640737)

  • 1. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
    Jennens RR; Giles GG; Fox RM
    Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced population.
    Mende M; Trautmann K; Rentsch A; Hornemann B; Schuler US; Ehninger G; Folprecht G
    BMC Cancer; 2013 Feb; 13():66. PubMed ID: 23391192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chemotherapy and novel biological agents in the treatment of elderly patients with colorectal cancer.
    Rosati G; Bilancia D
    World J Gastroenterol; 2008 Mar; 14(12):1812-22. PubMed ID: 18350617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of the impact of relaxing eligibility criteria on the risk-benefit profile of drugs for lung cancer based on real-world data.
    Huang H; Jia S; Wang X; Miao H; Fang H; He H; Wu D; Tang Y; Li N
    Thorac Cancer; 2024 May; 15(14):1187-1194. PubMed ID: 38576119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management.
    Kita K; Burdowski A
    World J Gastroenterol; 2024 Apr; 30(13):1780-1790. PubMed ID: 38659489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to assessing disparity in representativeness of clinical trial participants within a large midwestern healthcare system.
    Rivelli A; Lefaiver C; Shields M; Ozoani-Lohrer O; Marek A; Hirschtick J; Fitzpatrick V
    Contemp Clin Trials Commun; 2024 Apr; 38():101274. PubMed ID: 38390273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess mortality and undertreatment in elderly lung cancer patients: treatment nihilism in the modern era?
    Pham J; Conron M; Wright G; Mitchell P; Ball D; Philip J; Brand M; Zalcberg J; Stirling RG
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 34046489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between nutritional factors and chemotherapy toxicity in older adults with solid tumors.
    Dotan E; Tew WP; Mohile SG; Ma H; Kim H; Sun CL; Caan B; Dale W; Gajra A; Klepin HD; Owusu C; Gross CP; Muss H; Chapman A; Katheria V; Hurria A
    Cancer; 2020 Apr; 126(8):1708-1716. PubMed ID: 31977084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global reach of ageism on older persons' health: A systematic review.
    Chang ES; Kannoth S; Levy S; Wang SY; Lee JE; Levy BR
    PLoS One; 2020; 15(1):e0220857. PubMed ID: 31940338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and implementation of a dynamically updated big data intelligence platform from electronic health records for nasopharyngeal carcinoma research.
    Lin L; Liang W; Li CF; Huang XD; Lv JW; Peng H; Wang BY; Zhu BW; Sun Y
    Br J Radiol; 2019 Oct; 92(1102):20190255. PubMed ID: 31430186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Under-representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database.
    Ruiter R; Burggraaf J; Rissmann R
    Br J Clin Pharmacol; 2019 Apr; 85(4):838-844. PubMed ID: 30681181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.
    Nakao A; Hiranuma O; Uchino J; Sakaguchi C; Kita T; Hiraoka N; Ishizuka T; Kubota Y; Kawasaki M; Goto Y; Imai H; Hattori N; Nakatomi K; Uramoto H; Uryu K; Fukuda M; Uchida Y; Yokoyama T; Akai M; Mio T; Nagashima S; Chihara Y; Tamiya N; Kaneko Y; Mouri T; Yamada T; Yoshimura K; Fujita M; Takayama K
    Oncologist; 2019 May; 24(5):593-e170. PubMed ID: 30651400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol.
    Shen X; Diao M; Lu M; Feng R; Zhang P; Jiang T; Wang D
    BMJ Open; 2018 Feb; 8(2):e018519. PubMed ID: 29463588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of first-line pemetrexed plus carboplatin followed by single-agent pemetrexed maintenance in elderly Chinese patients with non-squamous non-small-cell lung cancer.
    Zhao X; Yu H; Zhao J; Wu X; Sun S; Luo Z; Wang H; Qiao J; Chang J; Wang J
    Oncotarget; 2017 Oct; 8(49):86384-86394. PubMed ID: 29156802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validity of randomized controlled trials in older adults, a systematic review.
    van Deudekom FJ; Postmus I; van der Ham DJ; Pothof AB; Broekhuizen K; Blauw GJ; Mooijaart SP
    PLoS One; 2017; 12(3):e0174053. PubMed ID: 28346503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016).
    Miura S; Maemondo M; Iwashima A; Harada T; Sugawara S; Kobayashi K; Inoue A; Nakagawa T; Takiguchi Y; Watanabe H; Ishida T; Terada M; Kagamu H; Gemma A; Yoshizawa H
    Invest New Drugs; 2017 Apr; 35(2):227-234. PubMed ID: 28150074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of Patients in Ongoing Clinical Trials on Lung Cancer.
    Schulkes KJ; Nguyen C; van den Bos F; van Elden LJ; Hamaker ME
    Lung; 2016 Dec; 194(6):967-974. PubMed ID: 27650509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
    Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancer.
    Zhai X; Yang L; Chen S; Zheng Q; Wang Z
    Cancer Med; 2016 Sep; 5(9):2286-93. PubMed ID: 27367482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival following segmentectomy or lobectomy in elderly patients with early-stage lung cancer.
    Zhang Y; Yuan C; Zhang Y; Sun Y; Chen H
    Oncotarget; 2016 Apr; 7(14):19081-6. PubMed ID: 26934652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.